In summary, our findings have shown that IL-20 expression in breast cancer is regulated by a transcriptional complex composed of transcription factors, including ER(α), GATA3, and FOXA1, as well as a transcriptional elongation factor, Ell3 (Figure 5). The gene discussed is ELL3; the disease is breast carcinoma.